Pfizer Unit's Patent For Antibiotic Drug OK'd By Fed. Circ.
The Federal Circuit held Tuesday that the Patent Trial and Appeal Board correctly upheld during an inter partes review the validity of the asserted claims of a Pfizer Inc. unit's patent...To view the full article, register now.
Already a subscriber? Click here to view full article